504 related articles for article (PubMed ID: 21550274)
1. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases.
Rekhi B; Deshmukh M; Jambhekar NA
Ann Diagn Pathol; 2011 Oct; 15(5):303-11. PubMed ID: 21550274
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
3. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
4. Hyalinizing spindle cell tumor with giant rosettes and low-grade fibromyxoid sarcoma: an immunohistochemical and ultrastructural comparative investigation.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2003; 27(5):349-55. PubMed ID: 14708726
[TBL] [Abstract][Full Text] [Related]
5. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
6. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas.
Folpe AL; Lane KL; Paull G; Weiss SW
Am J Surg Pathol; 2000 Oct; 24(10):1353-60. PubMed ID: 11023096
[TBL] [Abstract][Full Text] [Related]
7. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
8. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up.
Evans HL
Am J Surg Pathol; 2011 Oct; 35(10):1450-62. PubMed ID: 21921785
[TBL] [Abstract][Full Text] [Related]
9. Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types.
Hansen T; Katenkamp K; Brodhun M; Katenkamp D
Histopathology; 2006 Aug; 49(2):152-60. PubMed ID: 16879392
[TBL] [Abstract][Full Text] [Related]
10. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
[TBL] [Abstract][Full Text] [Related]
11. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
Bahrami A; Folpe AL
Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
[TBL] [Abstract][Full Text] [Related]
12. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
[TBL] [Abstract][Full Text] [Related]
13. [Low-grade fibromyxoid sarcoma: a clinicopathological analysis of 9 cases].
Lin J; Wang J; Yu LJ; Ying XL
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):302-6. PubMed ID: 19575871
[TBL] [Abstract][Full Text] [Related]
14. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
15. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features.
Oda Y; Takahira T; Kawaguchi K; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Histopathology; 2004 Jul; 45(1):29-38. PubMed ID: 15228441
[TBL] [Abstract][Full Text] [Related]
16. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing epithelioid fibrosarcoma of the oral cavity.
Elkins CT; Wakely PE
Head Neck Pathol; 2011 Dec; 5(4):428-31. PubMed ID: 21691827
[TBL] [Abstract][Full Text] [Related]
18. Low-grade fibromyxoid sarcoma of the small intestine: report of 4 cases with molecular cytogenetic confirmation.
Laurini JA; Zhang L; Goldblum JR; Montgomery E; Folpe AL
Am J Surg Pathol; 2011 Jul; 35(7):1069-73. PubMed ID: 21677541
[TBL] [Abstract][Full Text] [Related]
19. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Blay JY; Tlemsani C; Toulmonde M; Italiano A; Rios M; Bompas E; Valentin T; Duffaud F; Le Nail LR; Watson S; Firmin N; Dubray-Longeras P; Ropars M; Perrin C; Hervieu A; Lebbe C; Saada-Bouzid E; Soibinet P; Fiorenza F; Bertucci F; Boudou P; Vaz G; Bonvalot S; Honoré C; Marec-Berard P; Minard V; Cleirec M; Biau D; Meeus P; Babinet A; Dumaine V; Carriere S; Fau M; Decanter G; Gouin F; Ngo C; Le Loarer F; Karanian M; Meurgey A; Dufresne A; Brahmi M; Chemin-Airiau C; Ducimetiere F; Penel N; Le Cesne A;
Eur J Cancer; 2024 Jan; 196():113454. PubMed ID: 38008029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
